First Eagle Investment's BIO Position Overview
First Eagle Investment (via First Eagle Investment Management, LLC) currently holds 2.52 M shares of Bio-Rad Laboratories, Inc. (BIO) worth $706.67 M, representing 1.29% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, First Eagle Investment has maintained a strategic position in BIO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 951,123 shares.
Analysis based on 13F filings available since 2013 Q2
First Eagle Investment's Bio-Rad Laboratories (BIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Rad Laboratories (BIO) Trades by First Eagle Investment
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +191 | New Buy | 191 | $379.12 |
| Q3 2023 | +267 | Add 139.79% | 458 | $358.45 |
| Q4 2023 | +21 | Add 4.59% | 479 | $322.89 |
| Q1 2024 | +1,485 | Add 310.02% | 1,964 | $345.87 |
| Q2 2024 | +634,311 | Add 32296.89% | 636,275 | $273.11 |
| Q3 2024 | +76,725 | Add 12.06% | 713,000 | $334.58 |
| Q4 2024 | +505 | Add 0.07% | 713,505 | $328.51 |
| Q1 2025 | +852,685 | Add 119.51% | 1.57 M | $243.56 |
| Q2 2025 | +951,123 | Add 60.73% | 2.52 M | $241.32 |
| Q3 2025 | +3,006 | Add 0.12% | 2.52 M | $280.39 |
First Eagle Investment's Bio-Rad Laboratories Investment FAQs
First Eagle Investment first purchased Bio-Rad Laboratories, Inc. (BIO) in Q2 2023, acquiring 191 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment has held Bio-Rad Laboratories, Inc. (BIO) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment's largest addition to Bio-Rad Laboratories, Inc. (BIO) was in Q2 2025, adding 2,517,313 shares worth $607.48 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, First Eagle Investment's firm, First Eagle Investment Management, LLC, owns 2,520,319 shares of Bio-Rad Laboratories, Inc. (BIO), valued at approximately $706.67 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bio-Rad Laboratories, Inc. (BIO) represents approximately 1.29% of First Eagle Investment's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment's peak holding in Bio-Rad Laboratories, Inc. (BIO) was 2,520,319 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.